CoreCivic Gets $500M Buyback Expansion as Real-Estate Sale Boosts 3Q Profit

Dow Jones
Nov 05
 
 

CoreCivic said its board authorized a $500 million expansion to its stock-buyback program, as gains from a real-estate sale lifted its profit in the third quarter.

The government-solutions company said the expanded authorization brings the total program to $1.7 billion, of which $755.8 million remains available.

The company on Wednesday reported a profit of $1.34 billion, or $14.49 a share, compared with a profit of $26.3 million, or 24 cents a share. The recent profit included a $1.77 billion net gain from the company's sale of four detention facilities to the federal government.

Stripping out certain one-time items, adjusted earnings were 49 cents a share. Analysts polled by FactSet were expecting 43 cents a share.

Revenue rose to $744.1 million, up from $580.4 million a year prior. Analysts were expecting $690.5 million in revenue.

"We delivered strong financial results in a very active quarter, driven by increased demand for our services from U.S. Immigration and Customs Enforcement (ICE), including higher utilization of recently activated facilities, as well as the contribution from our acquisition of Clinical Solutions Pharmacy earlier this year," Chief Executive Lucibeth Mayberry said.

The company lifted its guidance for full-year adjusted earnings to a range of $1.74 to $1.80 a share, up from a range of $1.64 to $1.73 a share. Analysts currently expect $1.71 a share.

Shares of CoreCivic were roughly flat after-hours.

 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10